{"id":6586,"date":"2025-02-05T11:07:13","date_gmt":"2025-02-05T11:07:13","guid":{"rendered":"https:\/\/edren.org\/ren\/?page_id=6586"},"modified":"2025-03-14T17:17:38","modified_gmt":"2025-03-14T17:17:38","slug":"protocol-for-the-management-of-pd-peritonitis","status":"publish","type":"page","link":"https:\/\/edren.org\/ren\/handbook\/pd-handbook\/protocol-for-the-management-of-pd-peritonitis\/","title":{"rendered":"Protocol for the Management of PD Peritonitis- Summary Version"},"content":{"rendered":"<p>This is a summary version of the management of PD peritonitis in the Royal Infirmary of Edinburgh renal unit and can be printed via this link <a href=\"https:\/\/edren.org\/ren\/wp-content\/uploads\/2025\/02\/PD-Peritonitis-Protocol-Summary-final.docx\">PD Peritonitis Protocol Summary (final)<\/a>. More information will be available under relevant headings of the PD Protocol on Edren.<\/p>\n<p>_________________________________________________________________________________________________<\/p>\n<p><strong>PD-associated peritonitis<\/strong> can be diagnosed when at least <strong>two<\/strong> of the following are present:<\/p>\n<ul>\n<li>Clinical features consistent with peritonitis (abdominal pain, cloudy dialysis fluid)<\/li>\n<li>Dialysis fluid white cell count &gt;100\/\u00b5litre (or mm<sup>3<\/sup>) with &gt;50% polymorphonuclear leucocytes (PMNs)<\/li>\n<li>Positive culture from dialysis fluid<\/li>\n<\/ul>\n<p>_________________________________________________________________________________________________<\/p>\n<p><strong>Confirmation of Peritonitis<\/strong><\/p>\n<p>Take history, identifying possible episodes of contamination or recent PD-related infections. Clinical assessment of patient observations and examination specifically looking for evidence of exit site\/tunnel infection.<\/p>\n<p><strong>Essential samples:<\/strong><\/p>\n<ul>\n<li>Send 1x universal container to microbiology for <strong>urgent<\/strong> total\/differential white cell counts and gram stain<\/li>\n<li>Send PD fluid in anaerobic and aerobic blood culture bottles (10mls per bottle) labelled \u201cPD Fluid\u201d<\/li>\n<li>If exit site exudate present, swab and send for culture.<\/li>\n<\/ul>\n<p>Ensure sample is taken after a minimum 2 hour dwell. If abdomen dry, fill with 1 litre dwell for 2 hours then sample.<\/p>\n<p>_________________________________________________________________________________________________<\/p>\n<p><strong>Initial Antimicrobial Treatment (Day 0)<\/strong><\/p>\n<p><strong>Antibiotic therapy is given intra-peritoneally (IP) and should be initiated as soon as possible when WCC is found to be &gt;100<\/strong> <strong>\u00b5<\/strong><strong>litre<\/strong> but if clinical suspicion is high and\/or patient is unwell with evidence of sepsis, antibiotics should be given immediately after samples are taken, without waiting for PD cell count result.<\/p>\n<ul>\n<li><strong>Vancomycin 30mg\/kg (maximum 3g) IP <u>and<\/u> <\/strong><\/li>\n<li><strong>Ceftazidime 1.5g IP in 2 litre bag<\/strong><\/li>\n<li><strong>Oral anti-fungal prophylaxis Fluconazole 200mg alternate days for duration of antibiotics<\/strong><\/li>\n<\/ul>\n<p>Antibiotic therapy must cover both gram negative and gram positive organisms.<\/p>\n<p>Ceftazidime and Vancomycin can be given in to the same bag and are compatible with standard glucose bags and icodextrin. All IP antibiotics should be given via PD exchanges for a minimum dwell 6 hours. Patients can stay on APD.<\/p>\n<p><strong>If allergy to Vancomycin<\/strong>, Teicoplanin 15mg\/kg every 5 days or cefazolin 15mg\/kg daily can be used instead.<\/p>\n<p><strong>If allergy to Ceftazidime<\/strong>, Gentamicin 0.6 mg\/kg can be given but note the risk of\u00a0 vestibular\/ototoxicity so serum gentamicin levels should be monitored carefully. Please refer to relevant section on Edren website for further advice.<\/p>\n<p><strong>If previous clostridium difficile infection<\/strong>, consider Aztreonam 3g IP daily instead of Ceftazidime.<\/p>\n<p>Alternative antibiotics and their dosing\/stability in PD fluid is available elsewhere on Edren website.<\/p>\n<p>If concerns about fluconazole and drug interactions, give Nystatin 500,000 units QDS instead.<\/p>\n<p>_________________________________________________________________________________________________<\/p>\n<p><strong>Ongoing antimicrobial therapy and Vancomycin monitoring (Day 1 onward)<\/strong><\/p>\n<ul>\n<li><strong>Ceftazidime 1.5g IP daily<\/strong><\/li>\n<li><strong>Vancomycin aiming to keep trough 15-20 mg\/l (dose 30mg\/kg for subsequent doses)<\/strong><\/li>\n<li><strong>Oral antifungal prophylaxis for duration of antibiotics<\/strong><\/li>\n<\/ul>\n<p>First Vancomycin trough should be checked 48 hours after initial Vancomycin dose.<\/p>\n<ul>\n<li>If initial trough &gt;20mg\/l, a Vancomycin trough should be repeated 24 hrs later (and every 24 hr until &lt;20).<\/li>\n<li>If initial trough 10-20, further Vancomycin 30mg\/kg should be given and repeat trough level 48 hrs later.<\/li>\n<li>If initial trough &lt;10, further Vancomycin 30mg\/kg should be given and repeat trough checked 24 hrs later.<\/li>\n<li>Avoid Vancomycin trough &lt;12 mg\/l by more frequent monitoring and dosing as appropriate.<\/li>\n<\/ul>\n<p>Timing of subsequent vancomycin trough check will be guided by how quickly the vancomycin level fell &lt;20mg\/l (eg if it took 3 days for trough to fall &lt;20 then suggest checking trough 3 days after second dose). Patients with greater residual renal function will clear vancomycin more quickly.<\/p>\n<p>Both Ceftazidime and Vancomycin IP should continue until culture results are available.<\/p>\n<p>_________________________________________________________________________________________________<\/p>\n<p><strong>Management when Culture results available<\/strong><\/p>\n<p>Culture results are normally available by day 3. Note treatment varies according to organism cultured with some organisms requiring 3 weeks therapy or two antibiotics as summarised below: further information will be available under Organism Specific Peritonitis Management in separate section on Edren.<\/p>\n<p><strong>If culture negative<\/strong>, send further samples and discuss with microbiology to consider extended culture.<\/p>\n<p><em>Culture negative<\/em>\u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a02 weeks vancomycin <u>and<\/u> ceftazidime<\/p>\n<p><em>Gram positive cocci<\/em><strong> \u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 <\/strong>2 weeks vancomycin, stop ceftazidime<\/p>\n<p><em>MSSA or MRSA\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 <\/em><strong>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 <\/strong>3 weeks vancomycin, stop ceftazidime<\/p>\n<p><em>Streptococcus\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 <\/em>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 2 weeks vancomycin, stop ceftazidime<\/p>\n<p>Enterococci\u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a03 weeks vancomycin (or oral amoxicillin if sensitive)<\/p>\n<p>VRE\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 3 weeks oral linezolid<\/p>\n<p><em>Corynebacterium<\/em>\u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a02 weeks vancomycin, stop ceftazidime (If repeat episode, give 3 weeks vancomycin)<\/p>\n<p><em>Pseudomonas<\/em>\u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 3 weeks, stop vancomycin, needs <u>2 antibiotics<\/u> against gram negative<\/p>\n<p><em>Acinetobacter<\/em>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 3 weeks, stop vancomycin (IP meropenem or oral ciprofloxacin)<\/p>\n<p><em>Stenotophomonas<\/em>\u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a03 weeks, stop vancomycin, 2 antibiotics (according to sensitivities)<\/p>\n<p><em>Polymicrobial<\/em>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 3 weeks (consider GI pathology), antibiotics to cover all organisms<\/p>\n<p><em>Enteric gram negative<\/em>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 3 weeks,\u00a0 stop vancomycin, ceftazidime IP pending sensitivitie<\/p>\n<p><em>Serratia marcescens<\/em> \u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 3 weeks, stop vancomycin, stop ceftazidime\u00a0 give IP meropenem or ciprofloxacin PO<\/p>\n<p><em>Citrobacter<\/em> \u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 3 weeks, stop vancomycin, stop ceftazidime\u00a0 give IP meropenem or ciprofloxacin PO<\/p>\n<p><em>Morganella morgani<\/em> \u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 3 weeks, stop vancomycin, stop ceftazidime\u00a0 give IP meropenem or ciprofloxacin PO<\/p>\n<p><em>Enterobacter cloacae\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 <\/em>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 3 weeks, stop vancomycin, stop ceftazidime\u00a0 give IP meropenem or ciprofloxacin\u00a0 PO<\/p>\n<p><em>ESBL- producing\u00a0\u00a0 <\/em>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 3 weeks, stop vancomycin, stop ceftazidime\u00a0 give IP meropenem or oral ciprofloxacin<\/p>\n<p><em>CPE<\/em>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 3 weeks, stop vancomycin, seek microbiology advice<\/p>\n<p><em>Fungal<\/em>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 Catheter removal ASAP then 2 weeks treatment as per sensitivities<\/p>\n<p><em>Pasteurella multocida\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 <\/em>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 2 weeks, stop vancomycin, ceftazidime IP or co-amoxiclav (PO)<\/p>\n<p><em>Gordonia<\/em>\u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 3 weeks, stop vancomycin, 2 antibiotics (meropenem +gentamicin)<\/p>\n<p>Mycobacteriae\u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0Discuss with microbiology and infectious diseases specialist<\/p>\n<p>_________________________________________________________________________________________________<\/p>\n<p><strong>Assessing response to Treatment<\/strong><\/p>\n<p>If inpatient, send samples daily for WCC and culture. If outpatient send samples minimum Day 2 and Day 5 for WCC and culture hoping to see a falling WCC. If the patient is not improving and the WCC is not falling by day 5 despite appropriate antibiotics PD catheter removal is advised.<\/p>\n<p>_________________________________________________________________________________________________<\/p>\n<p><strong>Indications for Catheter Removal<\/strong><\/p>\n<p>PD catheter removal is a clinical decision but is recommended in the following circumstances:<\/p>\n<ul>\n<li>Fungal peritonitis (catheter must be removed in all cases, as soon as possible)<\/li>\n<li>Refractory peritonitis (ie no clinical improvement by day 5)<\/li>\n<li>Relapsing, recurrent or repeat peritonitis*<\/li>\n<li>Refractory exit site and\/or tunnel infection<\/li>\n<\/ul>\n<p>*At the discretion of the treating clinician but recommendation is after 2<sup>nd<\/sup> episode of staphylococcus aureus, 2<sup>nd<\/sup> episode pseudomonas, 3<sup>rd<\/sup> episode coagulase negative staphylococci (even if responding to treatment).<\/p>\n<p>If catheter is removed, appropriate antibiotic (minimum 14 days) or fungal therapy (minimum 14 days) should be continued. This could be iv or oral according to clinical condition and microbiology advice.<\/p>\n<p><strong>Notes:<\/strong><\/p>\n<ul>\n<li>Treatment can be inpatient or outpatient at the discretion of the treating team, based on the patient\u2019s clinical condition, frailty, social factors and practicalities of providing outpatient antibiotics.<\/li>\n<li>Inform community dialysis team ext 21219\/21220 as soon as possible if a PD patient presents with infection.<\/li>\n<li>This Protocol has been agreed nationally. Peritonitis and its management are audited by the Scottish Renal Registry quarterly and this data will inform future protocol revisions.<\/li>\n<li>It is recommended that a patient&#8217;s technique is reviewed after each peritonitis episode, with retraining considered on a case by case basis.<\/li>\n<li><em>(This version updated February 2025 by Dr M Petrie)<\/em><\/li>\n<\/ul>\n","protected":false},"excerpt":{"rendered":"<p>This is a summary version of the management of PD peritonitis in the Royal Infirmary of Edinburgh renal unit and can be printed via this link PD Peritonitis Protocol Summary (final). More information will be available under relevant headings of the PD Protocol on Edren. _________________________________________________________________________________________________ PD-associated peritonitis can be\u2026<\/p>\n<p> <a class=\"continue-reading-link\" href=\"https:\/\/edren.org\/ren\/handbook\/pd-handbook\/protocol-for-the-management-of-pd-peritonitis\/\"><span>Continue reading<\/span><i class=\"crycon-right-dir\"><\/i><\/a> <\/p>\n","protected":false},"author":14,"featured_media":0,"parent":6581,"menu_order":1,"comment_status":"closed","ping_status":"closed","template":"","meta":{"_lmt_disableupdate":"no","_lmt_disable":"","footnotes":""},"class_list":["post-6586","page","type-page","status-publish","hentry"],"_links":{"self":[{"href":"https:\/\/edren.org\/ren\/wp-json\/wp\/v2\/pages\/6586","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/edren.org\/ren\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/edren.org\/ren\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/edren.org\/ren\/wp-json\/wp\/v2\/users\/14"}],"replies":[{"embeddable":true,"href":"https:\/\/edren.org\/ren\/wp-json\/wp\/v2\/comments?post=6586"}],"version-history":[{"count":3,"href":"https:\/\/edren.org\/ren\/wp-json\/wp\/v2\/pages\/6586\/revisions"}],"predecessor-version":[{"id":6602,"href":"https:\/\/edren.org\/ren\/wp-json\/wp\/v2\/pages\/6586\/revisions\/6602"}],"up":[{"embeddable":true,"href":"https:\/\/edren.org\/ren\/wp-json\/wp\/v2\/pages\/6581"}],"wp:attachment":[{"href":"https:\/\/edren.org\/ren\/wp-json\/wp\/v2\/media?parent=6586"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}